© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
An expert dermatologist provides insight on approaching the optimal treatment and management of vitiligo.
December 22nd 2021
Amit G. Pandya, MD, FAAD, provides insight on the pathogenesis and differential diagnoses of vitiligo.
January 20th 2022
An expert dermatologist comments on the real-world impact of vitiligo and how it can affect a patient’s quality of life.
Dr Amit G. Pandya discusses the role of an HCP in motivating patients and setting their expectations for successfully managing and treating vitiligo.
January 27th 2022
Amit G. Pandya, MD, FAAD, reviews the goals of therapy for patients with vitiligo and considers factors that drive treatment decisions.
An expert dermatologist shares insight on the differences in response to vitiligo treatment based on different body parts being treated.
February 3rd 2022
Dr Amit G. Pandya discusses novel drugs in the pipeline for the treatment of vitiligo.
Amit G. Pandya, MD, FAAD, shares advice for the detection and treatment of vitiligo.
FDA Approves Baloxavir Marboxil to Treat, Prevent Flu in Younger At-Risk Children
COVID-19 Vaccination Rates Lower in Adults with Vision, Hearing Disabilities
Kidney-Urinary Tract Involvement with Intermediate Junctional Epidermolysis Bullosa